Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:13-HDoHE)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003730 AN006120 Virus infection of honey bee queens alters lipid profiles and indirectly suppresses a retinue pheromone component via reducing ovary mass Head tissue Honey bee Viral infection University of British Columbia LC-MS
ST003394 AN005568 Fatty acid oxygenated metabolites analysis of colon in Pla2g10 knockout mice. Colon Mouse Obesity University of Tokyo LC-MS
ST002455 AN004005 Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation Blood Mouse Sepsis University of Chicago LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST001951 AN003176 Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. Lung Mouse Pulmonary hypertension University of Tokyo LC-MS
ST001215 AN002026 Effect of Mirabegron Treatment on serum lipidome Blood Human Joslin Diabetes Center LC-MS
ST001214 AN002025 Lipidommics in the serum of human subjects Blood Human Joslin Diabetes Center LC-MS
ST001213 AN002024 Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice Blood Mouse Joslin Diabetes Center LC-MS
ST001207 AN002009 Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 Blood Mouse Joslin Diabetes Center LC-MS
ST001206 AN002008 Effects of cold exposure on serum lipidomic in mice Blood Mouse Joslin Diabetes Center LC-MS
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000221 AN000329 Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells Bone marrow Human Cancer Mayo Clinic LC-MS
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
ST000004 AN000004 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS LC-MS
  logo